Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study



Osmanov, Ismail ORCID: 0000-0003-3181-9601, Spiridonova, Ekaterina, Bobkova, Polina ORCID: 0000-0002-6604-7173, Gamirova, Aysylu, Shikhaleva, Anastasia, Andreeva, Margarita, Blyuss, Oleg, El-Taravi, Yasmin, DunnGalvin, Audrey ORCID: 0000-0002-1540-3959, Comberiati, Pasquale
et al (show 29 more authors) (2021) Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. [Preprint]

Access the full-text of this item by clicking on the Open Access link.

Abstract

<h4>Background: </h4> The long-term sequelae of coronavirus disease 2019 (Covid-19) in children remain poorly characterised. This study aimed to assess long-term outcomes in children previously hospitalised with Covid-19 and associated risk factors. Methods This is a prospective cohort study of children (18 years old and younger) admitted with confirmed Covid-19 to Z.A. Bashlyaeva Children's Municipal Clinical Hospital in Moscow, Russia. Children admitted to the hospital during the first wave of the pandemic, between April 2, 2020 and August 26, 2020, were included. Telephone interview using the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) Covid-19 Health and Wellbeing paediatric follow up survey. Persistent symptoms (>5 months) were further categorised by system(s) involved. Findings Overall, 518 of 853 (61%) of eligible children were available for the follow-up assessment and included in the study. Median age was 10.4 years (IQR, 3-15.2) and 270 (52.1%) were girls; median follow-up since hospital discharge was 256 (223-271) days. At the time of the follow-up interview 126 (24.3%) participants reported persistent symptoms among which fatigue (53, 10.7%), sleep disturbance (36, 6.9%,) and sensory problems (29, 5.6%) were the most common. Multiple symptoms were experienced by 44 (8.4%) participants. Risk factors for persistent symptoms were: age "6-11 years" (odds ratio 2.74 (95% confidence interval 1.37 to 5.75) and "12-18 years" (2.68, 1.41 to 5.4), and a history of allergic diseases (1.67, 1.04 to 2.67). Interpretation A quarter of children experienced persistent symptoms months after hospitalization with acute covid-19 infection, with almost one in ten experiencing multi-system involvement. Older age and allergic diseases were associated with higher risk of persistent symptoms at follow-up. Our findings highlight the need for replication and further investigation of potential mechanisms as well as clinical support to improve long term outcomes in children. Funding None.

Item Type: Preprint
Uncontrolled Keywords: Sechenov StopCOVID Research Team
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 30 Sep 2021 08:00
Last Modified: 18 Jan 2023 21:27
DOI: 10.1101/2021.04.26.21256110
Open Access URL: https://www.medrxiv.org/content/10.1101/2021.04.26...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3138712